Skip to content
How TwoXAR Is Using Big Data to Accelerate Drug Discovery episode artwork

Oct 27, 2016 25 min

How TwoXAR Is Using Big Data to Accelerate Drug Discovery

from The Bio Report Hosted by Levine Media Group

It can take up to six years to accumulate enough evidence to support advancing an experimental drug into clinical development. twoXAR is working to rapidly accelerate that process through the use of Big Data and its proprietary algorithms to find screen large public and proprietary data sets to indentify new drug candidates and determine their efficacy. We spoke to Andrew Radin, co-founder and CEO of twoXAR, about the company’s technology, how it’s being applied today, and the evolution of the company’s strategy.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

How TwoXAR Is Using Big Data to Accelerate Drug Discovery

0:00 25:20

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 25 minutes long.

When was this The Bio Report episode published?

This episode was published on October 27, 2016.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.